Tag Archives: Applied DNA Sciences

A Director at Applied DNA Sciences is Exercising Options

Today it was reported that a Director at Applied DNA Sciences (APDN – Research Report), John Bitzer, exercised options to buy 196,661 APDN shares at $0.54 a share, for a total transaction value of $106.2K. This recent transaction increases John

The CIO of Applied DNA Sciences is Exercising Options

Today it was reported that the CIO of Applied DNA Sciences (APDN – Research Report), Judith Murrah, exercised options to buy 49,165 APDN shares at $0.54 a share, for a total transaction value of $26.55K. This recent transaction increases Judith

The CEO of Applied DNA Sciences is Exercising Options

Today it was reported that the CEO of Applied DNA Sciences (APDN – Research Report), James Hayward, exercised options to buy 2,935,764 APDN shares at $0.54 a share, for a total transaction value of $1.59M. This recent transaction increases James

Maxim Group Keeps Their Hold Rating on Applied DNA Sciences (APDN)

Maxim Group analyst Anthony Vendetti maintained a Hold rating on Applied DNA Sciences (APDN – Research Report) yesterday. The company’s shares closed last Monday at $0.28, close to its 52-week low of $0.25. Vendetti observed: “Yesterday, after the Market close,

Maxim Group Keeps a Hold Rating on Applied DNA Sciences (APDN)

Maxim Group analyst Anthony Vendetti maintained a Hold rating on Applied DNA Sciences (APDN – Research Report) yesterday. The company’s shares opened today at $0.59. Vendetti commented: “2019, APDN announced that its cannabis partner, TheraCann International (private), secured an agreement

Maxim Group Thinks Applied DNA Sciences’ Stock is Going to Recover

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Applied DNA Sciences (NASDAQ: APDN) today and set a price target of $3. The company’s shares closed yesterday at $1.18, close to its 52-week low of $1.10. Vendetti commented: “Market